Open AccessFully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma
Author(s) -
Koji Matsuo,
Kenichi Tanabe,
Masae Ikeda,
Takeo Shibata,
Hiroshi Kajiwara,
Masaki Miyazawa,
Motoki Miyazawa,
Meiso Hayashi,
Masako Shida,
Takeshi Hirasawa,
Lynda D. Roman,
Mikio Mikami
Publication year - 2018
Publication title -
archives of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.793
H-Index - 68
eISSN - 1432-0711
pISSN - 0932-0067
DOI - 10.1007/s00404-018-4658-z
Subject(s) - medicine , hazard ratio , biomarker , serous fluid , ovarian cancer , stage (stratigraphy) , gastroenterology , confidence interval , oncology , carcinoma , serous carcinoma , cancer , paleontology , biochemistry , chemistry , biology
Fully sialylated alpha-chain of complement 4-binding protein (A2160) is a member of the glycoprotein family and has recently been identified as a diagnostic biomarker for epithelial ovarian cancer. This study examined the utility of A2160 as a prognostic biomarker for this disease.